Clinical Trials
2 trialsNCT00841113 2009-02-11
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Speciality European Pharma Limited
Phase 3 Completed
NCT00100243 2006-09-19
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
PRAECIS Pharmaceuticals Inc.
Phase 2 Completed